Xiong et al. observed that mast cells are able to block HCC cell metastasis by inhibiting the ERK1/2 pathway through the transfer of the exosomal miRNAs into HCC cells, thus providing new insights for the biological therapy of HCV-related HCC [125]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.